See more : Surgical Science Sweden AB (publ) (SUSRF) Income Statement Analysis – Financial Results
Complete financial analysis of International Flavors & Fragrances Inc. (IFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of International Flavors & Fragrances Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Collective Mining Ltd. (CNL.V) Income Statement Analysis – Financial Results
- Milestone Builder Holdings Limited (1667.HK) Income Statement Analysis – Financial Results
- Great-West Lifeco Inc. (GWLIF) Income Statement Analysis – Financial Results
- Serco Group plc (SCGPY) Income Statement Analysis – Financial Results
- Maple Leaf Foods Inc. (MFI.TO) Income Statement Analysis – Financial Results
International Flavors & Fragrances Inc. (IFF)
About International Flavors & Fragrances Inc.
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 11.48B | 12.44B | 11.66B | 5.08B | 5.14B | 3.98B | 3.40B | 3.12B | 3.02B | 3.09B | 2.95B | 2.82B | 2.79B | 2.62B | 2.33B | 2.39B | 2.28B | 2.10B | 1.99B | 2.03B | 1.90B | 1.81B | 1.84B | 1.46B | 1.44B | 1.41B | 1.43B | 1.44B | 1.44B | 1.32B | 1.19B | 1.13B | 1.02B | 962.80M | 869.50M | 839.50M | 745.90M | 620.70M | 501.00M |
Cost of Revenue | 7.80B | 8.29B | 7.92B | 3.00B | 3.03B | 2.29B | 1.92B | 1.72B | 1.67B | 1.73B | 1.67B | 1.65B | 1.68B | 1.53B | 1.39B | 1.42B | 1.32B | 1.21B | 1.17B | 1.16B | 1.09B | 1.04B | 1.06B | 762.31M | 735.40M | 714.50M | 722.90M | 731.00M | 706.30M | 641.40M | 578.70M | 548.00M | 498.50M | 474.60M | 433.00M | 414.10M | 372.60M | 311.00M | 245.90M |
Gross Profit | 3.68B | 4.15B | 3.74B | 2.09B | 2.11B | 1.68B | 1.48B | 1.40B | 1.35B | 1.36B | 1.28B | 1.18B | 1.10B | 1.09B | 935.13M | 970.63M | 952.21M | 884.13M | 824.40M | 873.42M | 809.06M | 773.41M | 780.33M | 700.49M | 704.10M | 692.80M | 703.90M | 705.10M | 733.20M | 673.80M | 609.90M | 578.40M | 518.50M | 488.20M | 436.50M | 425.40M | 373.30M | 309.70M | 255.10M |
Gross Profit Ratio | 32.07% | 33.37% | 32.04% | 41.03% | 41.10% | 42.31% | 43.52% | 44.89% | 44.71% | 44.10% | 43.49% | 41.66% | 39.62% | 41.66% | 40.20% | 40.62% | 41.83% | 42.19% | 41.36% | 42.95% | 42.55% | 42.75% | 42.32% | 47.89% | 48.91% | 49.23% | 49.33% | 49.10% | 50.93% | 51.23% | 51.31% | 51.35% | 50.98% | 50.71% | 50.20% | 50.67% | 50.05% | 49.90% | 50.92% |
Research & Development | 636.00M | 603.00M | 629.00M | 356.86M | 346.13M | 311.58M | 286.03M | 254.26M | 246.10M | 253.64M | 259.84M | 233.71M | 219.78M | 218.77M | 193.84M | 212.70M | 199.02M | 185.69M | 179.81M | 175.17M | 159.29M | 144.03M | 135.25M | 112.67M | 103.80M | 98.40M | 94.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 707.46M | 557.31M | 566.22M | 509.56M | 514.89M | 505.88M | 453.54M | 443.97M | 447.39M | 376.54M | 381.84M | 375.29M | 351.92M | 339.32M | 341.31M | 308.95M | 305.16M | 313.34M | 258.65M | 262.60M | 238.70M | 227.10M | 317.00M | 308.50M | 288.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.79B | 1.77B | 1.75B | 948.83M | 876.12M | 707.46M | 557.31M | 566.22M | 520.09M | 514.89M | 505.88M | 453.54M | 443.97M | 447.39M | 376.54M | 381.84M | 375.29M | 351.92M | 339.32M | 341.31M | 308.95M | 305.16M | 313.34M | 258.65M | 262.60M | 238.70M | 227.10M | 317.00M | 308.50M | 288.80M | 268.90M | 280.80M | 234.80M | 220.70M | 198.10M | 191.80M | 173.70M | 151.40M | 125.70M |
Other Expenses | 0.00 | 727.00M | 732.00M | 192.61M | 193.10M | 35.24M | 20.97M | 9.35M | -3.18M | 2.81M | 15.64M | -1.45M | 0.00 | 0.00 | 6.15M | 6.15M | 12.88M | 14.84M | 15.07M | 14.83M | 12.63M | 12.63M | 46.09M | 69.34M | 56.40M | 49.00M | 50.30M | 47.80M | 40.70M | 36.40M | 35.10M | 34.00M | 29.40M | 28.20M | 24.30M | 22.70M | 20.70M | 18.40M | 14.60M |
Operating Expenses | 5.79B | 3.10B | 3.11B | 1.50B | 1.42B | 1.09B | 878.03M | 844.25M | 766.19M | 768.53M | 765.72M | 687.25M | 663.76M | 666.16M | 576.54M | 600.69M | 587.19M | 552.46M | 534.21M | 531.31M | 480.87M | 461.82M | 494.67M | 440.67M | 422.80M | 386.10M | 371.80M | 364.80M | 349.20M | 325.20M | 304.00M | 314.80M | 264.20M | 248.90M | 222.40M | 214.50M | 194.40M | 169.80M | 140.30M |
Cost & Expenses | 13.62B | 11.39B | 11.03B | 4.50B | 4.44B | 3.39B | 2.80B | 2.56B | 2.44B | 2.49B | 2.43B | 2.33B | 2.35B | 2.20B | 1.97B | 2.02B | 1.91B | 1.76B | 1.70B | 1.69B | 1.57B | 1.50B | 1.56B | 1.20B | 1.16B | 1.10B | 1.09B | 1.10B | 1.06B | 966.60M | 882.70M | 862.80M | 762.70M | 723.50M | 655.40M | 628.60M | 567.00M | 480.80M | 386.20M |
Interest Income | 0.00 | 336.00M | 289.00M | 132.00M | 138.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 380.00M | 336.00M | 289.00M | 131.80M | 138.22M | 132.56M | 65.36M | 52.99M | 46.06M | 46.07M | 46.77M | 41.75M | 44.64M | 48.71M | 61.82M | 74.01M | 41.54M | 25.55M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.14B | 1.18B | 1.16B | 325.36M | 323.33M | 173.79M | 117.97M | 102.47M | 89.60M | 89.35M | 83.23M | 76.67M | 75.33M | 79.24M | 78.53M | 75.99M | 82.79M | 89.73M | 91.93M | 91.00M | 86.72M | 84.46M | 123.49M | 69.34M | 56.40M | 49.00M | 50.30M | 47.80M | 40.70M | 36.40M | 35.10M | 34.00M | 29.40M | 28.20M | 24.30M | 22.70M | 20.70M | 18.40M | 14.60M |
EBITDA | -996.00M | -110.00M | 1.80B | 897.68M | 1.02B | 753.60M | 719.59M | 678.58M | 674.76M | 684.21M | 615.00M | 561.84M | 493.51M | 487.54M | 412.89M | 430.52M | 442.62M | 428.56M | 402.17M | 470.21M | 414.92M | 396.06M | 409.15M | 329.16M | 337.70M | 355.75M | 382.40M | 388.10M | 424.70M | 385.00M | 341.00M | 297.60M | 283.70M | 267.50M | 238.40M | 233.60M | 199.60M | 158.30M | 129.40M |
EBITDA Ratio | -8.68% | 18.24% | 15.78% | 18.09% | 20.45% | 20.03% | 21.77% | 21.39% | 22.22% | 22.20% | 20.91% | 19.97% | 18.52% | 19.28% | 18.79% | 18.78% | 19.44% | 19.77% | 20.18% | 23.12% | 24.34% | 22.34% | 23.68% | 25.96% | 25.72% | 24.82% | 26.07% | 29.69% | 28.61% | 27.36% | 25.74% | 23.73% | 25.46% | 24.17% | 25.52% | 27.05% | 25.93% | 25.00% | 24.93% |
Operating Income | -2.11B | 1.09B | 585.00M | 566.48M | 665.27M | 583.88M | 581.44M | 567.36M | 577.82M | 592.32M | 518.49M | 488.29M | 440.90M | 416.36M | 358.59M | 351.73M | 365.03M | 328.99M | 266.88M | 310.28M | 285.77M | 311.60M | 285.66M | 259.82M | 281.30M | 306.70M | 332.10M | 340.30M | 384.00M | 348.60M | 305.90M | 263.60M | 254.30M | 239.30M | 214.10M | 210.90M | 178.90M | 139.90M | 114.80M |
Operating Income Ratio | -18.38% | 8.76% | 5.02% | 11.14% | 12.94% | 14.68% | 17.11% | 18.21% | 19.11% | 19.18% | 17.56% | 17.31% | 15.81% | 15.87% | 15.42% | 14.72% | 16.03% | 15.70% | 13.39% | 15.26% | 15.03% | 17.22% | 15.49% | 17.76% | 19.54% | 21.79% | 23.28% | 23.70% | 26.68% | 26.51% | 25.74% | 23.40% | 25.00% | 24.85% | 24.62% | 25.12% | 23.98% | 22.54% | 22.91% |
Total Other Income/Expenses | -408.00M | -299.00M | -231.00M | -125.11M | -157.55M | -136.13M | -100.26M | -43.64M | -49.25M | -43.26M | -55.06M | -44.87M | -67.36M | -67.06M | -63.74M | -91.42M | -36.34M | -15.39M | -44.01M | -61.11M | -33.91M | -45.18M | -97.88M | -75.69M | -37.80M | 4.40M | 8.10M | -41.20M | 9.70M | 11.70M | 17.90M | 17.90M | 15.20M | 12.80M | 9.00M | -1.60M | -3.50M | -600.00K | -2.20M |
Income Before Tax | -2.52B | -1.63B | 354.00M | 441.37M | 557.45M | 447.76M | 537.05M | 523.72M | 528.57M | 549.06M | 485.21M | 443.42M | 373.55M | 359.59M | 276.55M | 280.52M | 328.68M | 313.28M | 246.19M | 281.00M | 251.86M | 266.42M | 187.78M | 184.13M | 243.50M | 311.10M | 340.20M | 299.10M | 393.70M | 360.30M | 323.80M | 281.50M | 269.50M | 252.10M | 223.10M | 209.30M | 175.40M | 139.30M | 112.60M |
Income Before Tax Ratio | -21.94% | -13.06% | 3.04% | 8.68% | 10.85% | 11.26% | 15.80% | 16.81% | 17.48% | 17.78% | 16.43% | 15.72% | 13.40% | 13.71% | 11.89% | 11.74% | 14.44% | 14.95% | 12.35% | 13.82% | 13.25% | 14.73% | 10.18% | 12.59% | 16.92% | 22.11% | 23.84% | 20.83% | 27.35% | 27.40% | 27.24% | 24.99% | 26.50% | 26.18% | 25.66% | 24.93% | 23.52% | 22.44% | 22.48% |
Income Tax Expense | 45.00M | 211.00M | 75.00M | 74.00M | 97.18M | 107.98M | 241.38M | 118.69M | 116.91M | 134.52M | 131.67M | 189.28M | 106.68M | 96.04M | 81.02M | 50.89M | 81.56M | 86.78M | 53.12M | 84.93M | 79.26M | 90.47M | 71.78M | 61.12M | 81.50M | 107.30M | 122.00M | 109.20M | 144.90M | 134.30M | 121.30M | 104.80M | 100.80M | 95.40M | 84.50M | 80.60M | 68.40M | 53.60M | 42.90M |
Net Income | -2.57B | -1.84B | 268.00M | 365.00M | 455.87M | 337.30M | 295.67M | 405.03M | 411.67M | 414.54M | 353.54M | 254.13M | 266.87M | 263.56M | 195.53M | 229.63M | 247.13M | 226.50M | 193.07M | 196.07M | 172.60M | 175.94M | 116.00M | 123.01M | 162.00M | 203.80M | 218.20M | 189.90M | 248.80M | 226.00M | 202.50M | 170.60M | 168.70M | 156.70M | 138.60M | 128.70M | 107.00M | 85.70M | 69.70M |
Net Income Ratio | -22.35% | -14.76% | 2.30% | 7.18% | 8.87% | 8.48% | 8.70% | 13.00% | 13.62% | 13.42% | 11.97% | 9.01% | 9.57% | 10.05% | 8.41% | 9.61% | 10.85% | 10.81% | 9.69% | 9.64% | 9.08% | 9.72% | 6.29% | 8.41% | 11.25% | 14.48% | 15.29% | 13.22% | 17.28% | 17.18% | 17.04% | 15.15% | 16.59% | 16.28% | 15.94% | 15.33% | 14.35% | 13.81% | 13.91% |
EPS | -10.06 | -7.20 | 1.10 | 3.25 | 4.04 | 3.85 | 3.73 | 5.07 | 5.19 | 5.09 | 4.32 | 3.11 | 3.30 | 3.29 | 2.48 | 2.89 | 2.86 | 2.50 | 2.06 | 2.08 | 1.84 | 1.86 | 1.21 | 1.22 | 1.53 | 1.90 | 2.00 | 1.71 | 2.24 | 2.03 | 1.78 | 1.48 | 1.47 | 1.37 | 1.22 | 1.13 | 0.94 | 0.76 | 0.63 |
EPS Diluted | -10.06 | -7.20 | 1.10 | 3.20 | 4.00 | 3.83 | 3.72 | 5.05 | 5.16 | 5.06 | 4.29 | 3.09 | 3.26 | 3.26 | 2.46 | 2.86 | 2.82 | 2.48 | 2.04 | 2.05 | 1.83 | 1.84 | 1.20 | 1.22 | 1.53 | 1.90 | 1.99 | 1.70 | 2.24 | 2.03 | 1.77 | 1.48 | 1.47 | 1.37 | 1.22 | 1.13 | 0.94 | 0.76 | 0.63 |
Weighted Avg Shares Out | 255.00M | 255.00M | 243.00M | 112.16M | 111.97M | 87.55M | 79.07M | 79.65M | 80.45M | 80.94M | 81.32M | 81.11M | 80.46M | 79.50M | 78.40M | 79.03M | 86.54M | 90.60M | 93.72M | 94.26M | 93.80M | 94.59M | 95.87M | 100.82M | 105.88M | 107.26M | 109.10M | 111.05M | 111.07M | 111.33M | 113.76M | 115.27M | 114.76M | 114.38M | 113.61M | 113.89M | 113.83M | 112.76M | 110.63M |
Weighted Avg Shares Out (Dil) | 255.00M | 255.00M | 243.00M | 113.63M | 113.31M | 88.12M | 79.37M | 79.98M | 80.89M | 81.49M | 81.93M | 81.83M | 81.47M | 80.44M | 79.09M | 79.72M | 87.63M | 91.33M | 94.64M | 95.64M | 94.32M | 95.62M | 96.67M | 100.82M | 105.88M | 107.26M | 109.65M | 111.71M | 111.17M | 111.46M | 114.41M | 115.27M | 114.76M | 114.38M | 113.61M | 113.89M | 113.83M | 112.76M | 110.63M |
International Flavors (IFF) Up 2% Since Last Earnings Report: Can It Continue?
Roquette Successfully Completes Inaugural EUR 1.2 billion Bond Offering to Support its Transformative Acquisition of IFF Pharma Solutions
Morgan Stanley upgrades IFF to Overweight after stock pullback
IFF upgraded to Overweight from Equal Weight at Morgan Stanley
International Flavors (IFF) International Revenue Performance Explored
Fragrance Maker IFF Positioned For Growth With Revitalized R&D And Attractive Valuation: Analyst
Down -14.15% in 4 Weeks, Here's Why International Flavors (IFF) Looks Ripe for a Turnaround
International Flavors & Fragrances Inc. (IFF) Q3 2024 Earnings Call Transcript
International Flavors Q3 Earnings Miss Estimates, Sales Rise Y/Y
International Flavors (IFF) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Source: https://incomestatements.info
Category: Stock Reports